Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Probiotics

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...

Microbiota Modulation by Antibiotics

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...

Dysbiosis of the Gut Microbiota

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...

Introduction to the Human Microbiota

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Functions of the Gut Microbiota

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.

Anaerobe·2011

Same author

Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses.

Antimicrobial agents and chemotherapy·2008

Same author

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.

Antimicrobial agents and chemotherapy·2007

Same author

Fat distribution in relation to drug use, human immunodeficiency virus (HIV) status, and the use of antiretroviral therapies in Hispanic patients with HIV infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2003

Same author

Role of acquired immune deficiency syndrome-defining conditions in human immunodeficiency virus-associated wasting.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2003

Same author

Effect of preoperative neomycin-erythromycin intestinal preparation on the incidence of infectious complications following colon surgery. 1973.

Surgical infections·2003

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

Clinical indications for probiotics: an overview.

B R Goldin¹, S L Gorbach

¹Tufts University School of Medicine, Boston, Massachusetts 02111, USA. barry.goldin@tufts.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

|January 10, 2008

Summary

This summary is machine-generated.

Probiotics offer proven benefits for various conditions like diarrhea and allergies, with potential future applications in cancer and diabetes. Lactobacillus rhamnosus GG and Saccharomyces boulardii show the most significant health advantages.

Related Experiment Videos

Last Updated: Jul 8, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

Area of Science:

Microbiology
Gastroenterology
Immunology

Background:

Probiotic bacteria are utilized for managing a wide spectrum of human ailments.
Emerging research suggests novel applications for probiotics in future medical interventions.

Purpose of the Study:

To review the established and potential therapeutic applications of probiotic bacteria.
To identify specific probiotic strains with documented efficacy.

Main Methods:

Review of randomized double-blind studies and research investigations.
Analysis of evidence for probiotic effectiveness across various health conditions.

Main Results:

Probiotics are effective in treating acute and antibiotic-induced diarrhea.
Evidence supports prevention of food allergies, traveler's diarrhea, C. difficile colitis, and UTIs.
Potential benefits for respiratory infections, dental caries, IBS, and IBD are indicated.
Future applications may include cancer, diabetes, and rheumatoid arthritis.
Lactobacillus rhamnosus GG and Saccharomyces boulardii demonstrate the most extensive benefits.

Conclusions:

Probiotics possess a broad range of current and potential health benefits.
Specific strains like L. rhamnosus GG and S. boulardii are key players in probiotic therapy.
Continued research is warranted for exploring novel probiotic applications.